Myocardial Infarction: Etiology, Pathophysiology, And Modern Management Approaches
Keywords:
Myocardial infarction, Heart attack, Coronary artery disease, Atherosclerosis, Reperfusion therapy, Cardiac biomarkers, Percutaneous coronary intervention, Risk factors, Beta-blockers, Cardiac rehabilitationAbstract
Myocardial infarction (MI) remains one of the leading causes of morbidity and mortality worldwide, primarily resulting from acute occlusion of coronary arteries and subsequent myocardial ischemia. The incidence of MI continues to rise due to lifestyle changes, aging populations, and the prevalence of cardiovascular risk factors such as hypertension, diabetes mellitus, dyslipidemia, obesity, and smoking. The pathophysiology of MI involves atherosclerotic plaque rupture, platelet aggregation, thrombosis, and subsequent myocardial necrosis, which triggers inflammatory and neurohormonal responses that influence cardiac remodeling and patient outcomes [1][2].
Clinical manifestations of MI vary, ranging from typical chest pain, dyspnea, and diaphoresis to atypical presentations such as fatigue, syncope, or silent infarction, particularly in elderly patients and those with diabetes [3][4]. Early diagnosis is critical and is guided by electrocardiography, cardiac biomarkers (troponins, CK-MB), and imaging modalities such as echocardiography and coronary angiography [5][6].
Management strategies for MI include immediate reperfusion therapy, either via percutaneous coronary intervention (PCI) or thrombolytic therapy, alongside pharmacologic management with antiplatelet agents, anticoagulants, beta-blockers, ACE inhibitors, statins, and other adjunct therapies [7][8]. Secondary prevention emphasizes lifestyle modifications, risk factor control, cardiac rehabilitation, and adherence to guideline-directed medical therapy [9][10].
Recent research has focused on biomarker discovery, risk stratification tools, and novel pharmacologic agents to improve outcomes and reduce post-MI complications such as heart failure, arrhythmias, and recurrent ischemic events [11][12]. This article reviews the etiology, pathophysiology, clinical features, diagnostic modalities, and contemporary management of myocardial infarction, highlighting the importance of early intervention, comprehensive care, and patient-centered approaches for optimal outcomes.
References
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618–e651.
World Health Organization. Cardiovascular diseases (CVDs). WHO Fact Sheet. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129–2138.
Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528.
Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47(8 Suppl):C7–C12.
Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119–177.
Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes. Circulation. 2014;130:e344–e426.
Canto JG, Shlipak MG, Rogers WJ, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000;283(24):3223–3229.
O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. Circulation. 2013;127:e362–e425.
Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Circulation. 2007;116:2634–2653.
Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119–177.
Antman EM, Loscalzo J. Ischemic heart disease. In: Bonow RO, Mann DL, Zipes DP, Libby P, editors. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia: Elsevier; 2019. p. 1259–1314